Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05315258 |
| Title | Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma (TebeMRD) |
| Acronym | TebeMRD |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University of Oxford |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Cambridge University Hospitals NHS Foundation Trust (Screening only) | Cambridge | United Kingdom | Details | |||
| The Beatson West of Scotland Cancer Centre | Glasgow | United Kingdom | Details | |||
| The Clatterbridge Cancer Centre | Liverpool | United Kingdom | Details | |||
| University College London Hospital | London | United Kingdom | Details | |||
| The Christie Hospital | Manchester | United Kingdom | Details | |||
| Mount Vernon Cancer Centre | Middlesex | United Kingdom | Details | |||
| Newcastle upon Tyne Hospitals NHS Foundation Trust | Newcastle | United Kingdom | Details | |||
| Churchill Hospital, Oxford University Hospitals NHS Trust | Oxford | OX3 7LE | United Kingdom | Details | ||
| Sheffield Teaching Hospitals NHS Foundation Trust (Screening only) | Sheffield | United Kingdom | Details | |||
| University Hospital Southampton NHS Foundation Trust | Southampton | United Kingdom | Details |